The ACTA2015 Symposium was held between the 7th - 10th October 2015 at the Hilton Hotel, Sydney.  The Symposium brought together the largest ever multi-disciplinary, cross-specialty faculty of invited international and national speakers to present at an Australian meeting solely dedicated to improving the role, value and conduct of clinical trials.  

Across four packed days the ACTA 2015 program addressed global trends towards embedding clinical trials in clinical care, challenges in trial design and conduct, maximising the value of clinical registries and improving public awareness and consumer involvement in clinical research. 

More than 500 leading clinical researchers and health and research policymakers from around Australia participated in what was a fantastic melting pot of expertise, innovation, vision and enthusiasm. We extend our sincere thanks to all who contributed to make this meeting such a resounding success.

 

"It was fantastic; one of the best conferences I've attended - I can't emphasise enough the quality of the international speakers. The national speakers were also of an outstanding calibre too..."

ACTA 2015 Delegate

 

ACTA 2015 presentations

Copies of available presentations from the ACTA 2015 Symposium can be viewed via the official ACTA 2015 website.

 

thank you to our speakers...

Invited International Speakers

1. Professor Donald Berry, Professor of Biostatistics, Univ of Texas M.D. Anderson Cancer Center
2. Professor Dame Sally Davies, Chief Medical Officer, UK (appeared by Video)
3. Professor Richard Horton, Editor in Chief, The Lancet
4. Ms Susan Marlin, President and CEO Clinical Trials Ontario
5. Professor Kathy Rowan, Director of Scientific & Strategic Development, Intensive Care National Audit & Research Centre (ICNARC)
6. Dr Joe Selby, Executive Director, Patient Centred Outcomes Research Institute (PCORI) USA
7. Professor Tom Walley CBE, Director of the NIHR HTA Programme, Professor of Clinical Pharmacology at Liverpool University, Consultant Physician at Royal Liverpool University Hospital.

Invited National Speakers

8. Dr Martin Cross, Chairman of Medicines Australia
9. Prof Anne Kelso, NHMRC CEO
10. Prof Chris Baggoley, Chief Medical Officer of the Department of Health
11. Dr Saraid Billiards, Director, Research Grants, NHMRC
12. A/Prof Laima Brazionis, Director, TEAMSnet
13. Prof Derek Chew, Regional Director of Cardiology, Southern Adelaide Local Health Network
14. Mr James Cokayne, Research Ethics and Governance Unit, NSW OHMR
15. Prof Caroline Crowther, Professor of Maternal and Perinatal Health, The Liggins Institute, University of Auckland
16. Ms Melinda Cruz, CEO Miracle Babies Foundation
17. Prof Geoffrey Donnan AO, Director, The Florey Institute for Neurosciences and Mental Health
18. A/Prof Adam Elshaug, Director, Value in Healthcare Division, Menzies Centre for Health Policy, University of Sydney
19. A/Prof Sue Evans, Head, Centre of Research Excellence in Patient Safety, SPHPM, Monash University
20. Prof Andrew Forbes, Head of Biostatistics, SPHPM, Monash University
21. Prof John Forbes AM, Director of Research, Australian and New Zealand Breast Cancer Trials Group
22. Prof Val Gebski, Head of Biostatistics, NHMRC Clinical Trials Centre
23. Dr Suzanne Hasthorpe, Manager, Coordinating Officer for Clinical Trials, Victorian Department of Health
24. Prof Ian Hickie AM, Co-Director, Health and Policy, Brain and Mind Centre
25. Prof David Howells, The Florey Institute for Neurosciences and Mental Health
26. Mr Tim James, CEO Medicines Australia
27. Mr Mitch Kirkman, Development Quality Assurance Manager, Novartis
28. Prof Paul Komesaroff, Director, Centre for Ethics, Monash University
29. Dr Gordon McGurk, Director, Clinical Trials Section, NHMRC
30. Prof John McNeil AM, Head, School of Public Health and Preventive Medicine, Monash University
31. A/Prof Jodie McVernon, Head, Modeling and Simulation, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health
32. Prof Ben Mol, Professor of Obstetrics and Gynaecology, University of Adelaide
33. Prof Peter Morris, Professor of Paediatrics, Menzies School of Health Research
34. Prof Mark Nelson, Professor and Chair, General Practice, University of Tasmania
35. Prof Stephen Nicholls, Deputy Director, SAHMRI
36. Prof Vlado Perkovic, Executive Director, George Institute for Global Health Australia and George Clinical
37. Prof Sally Redman AO, CEO, Sax Institute
38. Ms Samantha Robertson, Executive Director, Evidence, Advice and Governance, NHMRC
39. A/Prof Clare Scott, Medical Oncologist and Laboratory Head, Walter and Eliza Hall Institute of Medical Research
40. Prof David Thomas, Head, Cancer Division, Garvan Institute of Medical Research
41. Prof Colin Thompson, Professor of Law and Academic Leader for Health Law and Ethics, Graduate School of Medicine, University of Wollongong
42. Prof Steve Webb, Senior Staff Specialist in Intensive Care, Royal Perth Hospital & Clinical Professor, University of Western Australia and Monash University
43. Prof Steve Wesselingh, Executive Director, SAHMRI
44. Prof Ingrid Winship, Director of Research, Melbourne Health and University of Melbourne
45. Prof John Zalcberg OAM, Professor of Cancer Research, School of Public & Preventative Medicine, Monash University

 

and thank you to our sponsors and partners

 

Principle Partner

 

Major Supporter

           

 

 

 

Major Partner

 

 

Gold Partners

 

 

Bronze Partners

 

 

 

   

 

 

 

Symposium Sponsors